PubMed:20973483
Annnotations
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
8197 | 35-71 | ChemicalEntity | denotes | adenosine A2A/A1 receptor antagonist | MESH:D058915 |
8198 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | MESH:D010300 |
8199 | 152-192 | ChemicalEntity | denotes | adenosine A(2A)/A(1) receptor antagonist | MESH:D058915 |
8200 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | MESH:D010300 |
8201 | 441-471 | ChemicalEntity | denotes | A(2A)/A(1) receptor antagonist | MESH:D058915 |
8202 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | MESH:D010300 |
8203 | 646-651 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
8204 | 656-659 | OrganismTaxon | denotes | rat | NCBITaxon:10116 |
8205 | 670-681 | ChemicalEntity | denotes | haloperidol | MESH:D006220 |
8206 | 690-699 | DiseaseOrPhenotypicFeature | denotes | catalepsy | MESH:D002375 |
8207 | 701-706 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
8208 | 716-725 | ChemicalEntity | denotes | reserpine | MESH:D012110 |
8209 | 734-742 | DiseaseOrPhenotypicFeature | denotes | akinesia | MESH:D004409 |
8210 | 744-747 | OrganismTaxon | denotes | rat | NCBITaxon:10116 |
8211 | 748-765 | ChemicalEntity | denotes | 6-hydroxydopamine | MESH:D016627 |
8212 | 767-773 | ChemicalEntity | denotes | 6-OHDA | MESH:D016627 |
8213 | 818-822 | ChemicalEntity | denotes | MPTP | MESH:D015632 |
8214 | 835-840 | OrganismTaxon | denotes | human | NCBITaxon:9606 |
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-112 | Sentence | denotes | In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease. |
T2 | 113-254 | Sentence | denotes | The in vivo characterization of a dual adenosine A(2A)/A(1) receptor antagonist in several animal models of Parkinson's disease is described. |
T3 | 255-417 | Sentence | denotes | Discovery and scale-up syntheses of compound 1 are described in detail, highlighting optimization steps that increased the overall yield of 1 from 10.0% to 30.5%. |
T4 | 418-855 | Sentence | denotes | Compound 1 is a potent A(2A)/A(1) receptor antagonist in vitro (A(2A) K(i) = 4.1 nM; A(1) K(i) = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson's disease including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and MPTP-treated non-human primate model. |
LitCoin-entities-OrganismTaxon-PD
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 646-651 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
T3 | 656-659 | OrganismTaxon | denotes | rat | NCBItxid:10116|NCBItxid:10114 |
T5 | 701-706 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
T7 | 744-747 | OrganismTaxon | denotes | rat | NCBItxid:10116|NCBItxid:10114 |
T9 | 835-840 | OrganismTaxon | denotes | human | NCBItxid:9606 |
T10 | 841-848 | OrganismTaxon | denotes | primate | NCBItxid:9443 |
LitCoin_Mondo
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
T2 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
T3 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
LitCoin-SeqVar
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 45-48 | SequenceVariant | denotes | A2A |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 49-51 | GeneOrGeneProduct | denotes | A1 |
T2 | 52-60 | GeneOrGeneProduct | denotes | receptor |
T3 | 61-71 | GeneOrGeneProduct | denotes | antagonist |
T4 | 162-169 | GeneOrGeneProduct | denotes | A(2A)/A |
T5 | 173-181 | GeneOrGeneProduct | denotes | receptor |
T6 | 182-192 | GeneOrGeneProduct | denotes | antagonist |
T7 | 353-358 | GeneOrGeneProduct | denotes | steps |
T8 | 386-391 | GeneOrGeneProduct | denotes | yield |
T9 | 441-448 | GeneOrGeneProduct | denotes | A(2A)/A |
T10 | 452-460 | GeneOrGeneProduct | denotes | receptor |
T11 | 461-471 | GeneOrGeneProduct | denotes | antagonist |
T12 | 499-507 | GeneOrGeneProduct | denotes | nM; A(1) |
T13 | 543-551 | GeneOrGeneProduct | denotes | activity |
T14 | 682-689 | GeneOrGeneProduct | denotes | induced |
T15 | 726-733 | GeneOrGeneProduct | denotes | induced |
T16 | 775-781 | GeneOrGeneProduct | denotes | lesion |
T17 | 796-803 | GeneOrGeneProduct | denotes | induced |
T18 | 818-822 | GeneOrGeneProduct | denotes | MPTP |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 52-60 | GeneOrGeneProduct | denotes | receptor |
T2 | 173-181 | GeneOrGeneProduct | denotes | receptor |
T3 | 452-460 | GeneOrGeneProduct | denotes | receptor |
T4 | 818-822 | GeneOrGeneProduct | denotes | MPTP |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T1 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T2 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T3 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T4 | 690-699 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
LitCoin-GeneOrGeneProduct-v3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 818-822 | GeneOrGeneProduct | denotes | MPTP |
LitCoin_Mondo_095
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
T2 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
T3 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T1 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T2 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T3 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T4 | 690-699 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
T5 | 734-742 | DiseaseOrPhenotypicFeature | denotes | akinesia | DISEASE |
LitCoin-NCBITaxon-2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 646-651 | OrganismTaxon | denotes | mouse |
T2 | 656-659 | OrganismTaxon | denotes | rat |
T3 | 701-706 | OrganismTaxon | denotes | mouse |
T4 | 744-747 | OrganismTaxon | denotes | rat |
T5 | 835-840 | OrganismTaxon | denotes | human |
T6 | 841-848 | OrganismTaxon | denotes | primate |
LitCoin-MONDO_bioort2019
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T1 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T2 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T3 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
T4 | 690-699 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
T5 | 734-742 | DiseaseOrPhenotypicFeature | denotes | akinesia | DISEASE |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T1 | 35-71 | ChemicalEntity | denotes | adenosine A2A/A1 receptor antagonist | ChemicalEntity |
T2 | 152-161 | ChemicalEntity | denotes | adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 |
T3 | 670-681 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T5 | 716-725 | ChemicalEntity | denotes | reserpine | D012110|http://purl.obolibrary.org/obo/CHEBI_28487 |
T7 | 748-765 | ChemicalEntity | denotes | 6-hydroxydopamine | D016627|http://purl.obolibrary.org/obo/CHEBI_78741 |
T9 | 767-773 | ChemicalEntity | denotes | 6-OHDA | D016627|http://purl.obolibrary.org/obo/CHEBI_78741 |
T11 | 818-822 | ChemicalEntity | denotes | MPTP | D015632|http://purl.obolibrary.org/obo/CHEBI_17963 |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
---|---|---|---|---|---|---|
T11 | 818-822 | ChemicalEntity | denotes | MPTP | http://purl.obolibrary.org/obo/CHEBI_17963|D015632 | |
T9 | 767-773 | ChemicalEntity | denotes | 6-OHDA | http://purl.obolibrary.org/obo/CHEBI_78741|D016627 | |
T7 | 748-765 | ChemicalEntity | denotes | 6-hydroxydopamine | http://purl.obolibrary.org/obo/CHEBI_78741|D016627 | |
T5 | 716-725 | ChemicalEntity | denotes | reserpine | http://purl.obolibrary.org/obo/CHEBI_28487|D012110 | |
T3 | 670-681 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T2 | 152-161 | ChemicalEntity | denotes | adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 | |
T1 | 35-71 | ChemicalEntity | denotes | adenosine A2A/A1 receptor antagonist | ChemicalEntity | |
T94575 | 818-822 | GeneOrGeneProduct | denotes | MPTP | ||
T72561 | 734-742 | DiseaseOrPhenotypicFeature | denotes | akinesia | DISEASE | |
T4 | 690-699 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 | |
T39398 | 616-635 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 | |
T74617 | 221-240 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 | |
T76672 | 92-111 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 | |
T6 | 841-848 | OrganismTaxon | denotes | primate | ||
T2268 | 835-840 | OrganismTaxon | denotes | human | ||
T91669 | 744-747 | OrganismTaxon | denotes | rat | ||
T99223 | 701-706 | OrganismTaxon | denotes | mouse | ||
T36597 | 656-659 | OrganismTaxon | denotes | rat | ||
T99238 | 646-651 | OrganismTaxon | denotes | mouse | ||
T62420 | 45-48 | SequenceVariant | denotes | A2A |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 221-230 | HP_0001300 | denotes | Parkinson |
T2 | 616-625 | HP_0001300 | denotes | Parkinson |
T3 | 734-742 | HP_0002304 | denotes | akinesia |